CONSULTING AGREEMENTConsulting Agreement • May 10th, 2019 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
THIS CONSULTING AGREEMENT (the “Agreement”), made this 12th day of November, 2018, is entered into by Spark Therapeutics, Inc., a Delaware corporation with an address of 3737 Market Street, Suite 1300, Philadelphia, Pennsylvania 19104 (the “Company”), and John P. Furey an individual residing at 446 Boxwood Road, Bryn Mawr, PA 19010 (the “Consultant”).
